Introduction
Candidiasis - Overview
Candidiasis - Therapeutics Development
Candidiasis - Therapeutics Assessment
Candidiasis - Companies Involved in Therapeutics Development
Candidiasis - Drug Profiles
Candidiasis - Dormant Projects
Candidiasis - Discontinued Products
Candidiasis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Candidiasis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Products under Development by Universities/Institutes, H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Candidiasis - Pipeline by Acea Biotech Inc, H1 2020
Candidiasis - Pipeline by Amplyx Pharmaceuticals Inc, H1 2020
Candidiasis - Pipeline by APEIRON Biologics AG, H1 2020
Candidiasis - Pipeline by Autoimmune Technologies LLC, H1 2020
Candidiasis - Pipeline by Bakker Medical Srl, H1 2020
Candidiasis - Pipeline by Beta Pharma Inc, H1 2020
Candidiasis - Dormant Projects, H1 2020
Candidiasis - Dormant Projects, H1 2020 (Contd..1), H1 2020
Candidiasis - Dormant Projects, H1 2020 (Contd..2), H1 2020
Candidiasis - Dormant Projects, H1 2020 (Contd..3), H1 2020
Candidiasis - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Candidiasis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• Acea Biotech Inc
• Amplyx Pharmaceuticals Inc
• APEIRON Biologics AG
• Autoimmune Technologies LLC
• Bakker Medical Srl
• Beta Pharma Inc
• Biokawthar Technologies SAS
• Biomendics LLC
• Biosergen AS
• Cellix Bio Pvt Ltd
• Cidara Therapeutics Inc
• CSA Biotechnologies LLC
• CSPC Pharmaceutical Group Ltd
• Fox Chase Chemical Diversity Center Inc
• Fujifilm Toyama Chemical Co Ltd
• General Biologicals Corp
• Grupo Ferrer Internacional SA
• Helix BioMedix Inc
• Hennepin Life Sciences LLC
• iCo Therapeutics Inc
• iNtRON Biotechnology Inc
• Matinas BioPharma Holdings Inc
• Mycovia Pharmaceuticals Inc
• Nanomerics Ltd
• Next Science Ltd
• Nosopharm SAS
• Novabiotics Ltd
• NovaDigm Therapeutics Inc
• Novartis AG
• Oryn Therapeutics
• Profem GmbH
• Pulmocide Ltd
• Sano Chemicals Inc
• Scynexis Inc
• Sealife PHARMA GMBH
• Shaanxi Synthetic Pharmaceutical Co Ltd
• Stadius Biopharma LLC
• TGV Laboratories Inc
• TGV Therapeutics
• Toltec Pharmaceuticals LLC
• Visterra Inc
• Wellstat Vaccines LLC